Los Angeles Capital Management LLC acquired a new position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 29,620 shares of the company’s stock, valued at approximately $576,000. A […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Brokerages forecast that Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) will report sales of $2.90 million for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Rhythm Pharmaceuticals’ earnings, with the highest sales estimate coming in at $3.50 million and the lowest estimate coming in at $2.30 million. Rhythm Pharmaceuticals reported […]
Equities research analysts expect Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) to post sales of $2.90 million for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Rhythm Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $2.30 million and the highest estimate coming in at $3.50 million. Rhythm Pharmaceuticals […]